Masimo to Present at 24th Annual Piper Jaffray Health Care Conference

    Masimo to Present at 24th Annual Piper Jaffray Health Care Conference

PR Newswire

IRVINE, Calif., Nov. 14, 2012

IRVINE, Calif., Nov. 14, 2012 /PRNewswire/ --Masimo (NASDAQ: MASI) today
announced that its management is scheduled to present at the 24th Annual Piper
Jaffray Health Care Conferenceat the New York Palace Hotelin New York on
Wednesday, November 28, 2012, at 2:00 p.m. Eastern Time. A live audiocast of
the presentation will be available on the Masimo website at www.masimo.com. A
replay of the audiocast will be available following the live presentation.

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive
monitoring technologies that significantly improve patient care—helping solve
"unsolvable" problems. In 1995, the company debuted Measure-Through Motion and
Low Perfusion pulse oximetry, known as Masimo SET^®, which virtually
eliminated false alarms and increased pulse oximetry's ability to detect
life-threatening events. More than 100 independent and objective studies have
shown that Masimo SET^® outperforms other pulse oximetry technologies, even
under the most challenging clinical conditions, including patient motion and
low peripheral perfusion. In 2005, Masimo introduced rainbow SET^® Pulse
CO-Oximetry technology, allowing noninvasive and continuous monitoring of
blood constituents that previously required invasive procedures, including
total hemoglobin (SpHb^®), oxygen content (SpOC^TM), carboxyhemoglobin
(SpCO^®), methemoglobin (SpMet^®), and Pleth Variability Index (PVI^®), in
addition to SpO2, pulse rate, and perfusion index (PI). In 2008, Masimo
introduced Patient SafetyNet™, a remote monitoring and wireless clinician
notification system designed to help hospitals avoid preventable deaths and
injuries associated with failure to rescue events. In 2009, Masimo introduced
rainbow^® Acoustic Monitoring^TM, the first-ever noninvasive and continuous
monitoring of acoustic respiration rate (RRa™). Masimo's rainbow^® SET^®
technology platform offers a breakthrough in patient safety by helping
clinicians detect life-threatening conditions and helping guide treatment
options. In 2010, Masimo acquired SedLine^®, a pioneer in the development of
innovative brain function monitoring technology and devices. And in 2012,
Masimo acquired the assets of Spire Semiconductor, LLC, maker of advanced
light emitting diode (LED) and other advanced component-level technologies;
and Phasein AB, a developer and manufacturer of ultra-compact mainstream and
sidestream capnography, multigas analyzers, and handheld capnometry solutions.
Masimo SET^® and Masimo rainbow^® SET^® technologies also can be found in over
100 multiparameter patient monitors from over 50 medical device manufacturers
around the world. Founded in 1989, Masimo has the mission of "Improving
Patient Outcome and Reducing Cost of Care … by Taking Noninvasive Monitoring
to New Sites and Applications^®." Additional information about Masimo and its
products may be found at www.masimo.com.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and
Reducing Cost of Care… by Taking Noninvasive Monitoring to New Sites and
Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Rainbow Acoustic
Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5, Pulse CO-Oximetry,
Pulse CO-Oximeter, and SEDLine are trademarks or registered trademarks of
Masimo Corporation.

Contact:
Sheree Aronson
(949) 297-7043
saronson@masimo.com


SOURCE Masimo

Website: http://www.masimo.com
 
Press spacebar to pause and continue. Press esc to stop.